Beta-Blockers after Myocardial Infarction: Do Benefits Ever Outweigh Risks in Asthma?

By  

Cardiology, Vol. 92, Iss. 2, 2000-03 ,pp. : 99-105

Karger

Access to resources Recommend Favorite

Underutilization of Beta‐Blockers in Older Patients With Prior Myocardial Infarction or Coronary Artery Disease in an Academic, Hospital‐Based Geriatrics Practice

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 45, Iss. 11, 1997-11 ,pp. : 1360-1361

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intracoronary Compared to Intravenous Abciximab in Patients with ST Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention Reduces Mortality, Target Vessel Revascularization and Reinfarction after 1 Year

By  

Cardiology, Vol. 120, Iss. 1, 2011-11 ,pp. : 43-49

Karger

Access to resources Recommend Favorite

Effects of a secondary prevention combination therapy with an aspirin, an ACE inhibitor and a statin on 1-year mortality of patients with acute myocardial infarction treated with a beta-blocker. Support for a polypill approach

By Zeymer Uwe   Jüünger Claus   Zahn Ralf   Bauer Timm   Bestehorn Kurt   Senges Jochen   Gitt Anselm  

Current Medical Research and Opinion, Vol. 27, Iss. 8, 2011-08 ,pp. : 1563-1570

Informa Healthcare

Access to resources Recommend Favorite

Early Use of Beta-Blockers Is Associated with Attenuation of Serum C-Reactive Protein Elevation and Favorable Short-Term Prognosis after Acute Myocardial Infarction

By  

Cardiology, Vol. 99, Iss. 1, 2003-02 ,pp. : 47-53

Karger

Access to resources Recommend Favorite